Illumina Inc (ILMN.O)
299.82USD
15 Feb 2019
$0.00 (+0.00%)
$299.82
--
--
--
3
1,166,502
$372.61
$221.49
About
Overall
| Beta: | 1.15 |
| Market Cap(Mil.): | $44,073.54 |
| Shares Outstanding(Mil.): | 147.00 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ILMN.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 53.46 | 70.14 | 35.99 |
| EPS (TTM): | 5.61 | -- | -- |
| ROI: | 17.06 | 6.20 | 12.72 |
| ROE: | 25.73 | 8.74 | 13.73 |
Illumina to buy rival Pacific Biosciences in $1.2 billion deal
Gene sequencing company Illumina Inc said http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20181101:nBw18KCRQa on Thursday it plans to buy smaller rival Pacific Biosciences of California Inc in an all-cash deal valued at $1.2 billion, expanding its capabilities as the market grows.
UPDATE 1-Illumina to buy rival Pacific Biosciences in $1.2 bln deal
Nov 1 Gene sequencing company Illumina Inc said http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20181101:nBw18KCRQa on Thursday it plans to buy smaller rival Pacific Biosciences of California Inc in an all-cash deal valued at $1.2 billion, expanding its capabilities as the market grows.
Gene sequencing company Illumina to buy Pacific Biosciences in $1.2 bln deal
Nov 1 Gene sequencing company Illumina Inc said http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20181101:nBw18KCRQa on Thursday it plans to buy Pacific Biosciences of California Inc in an all-cash deal valued at $1.2 billion.
Estimates